Amgen 🧪🔬🧬 (@Amgen) / X

Amgen 🧪🔬🧬

14.1K posts

Amgen 🧪🔬🧬

@Amgen

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases. 🔗 Guidelines: amgen.ly/RpcA3B

Thousand Oaks, CA, USA

wwwext.amgen.com

Born April 8, 1980

Joined April 2009

Pinned
Amgen 🧪🔬🧬
@Amgen
Jul 9
Competitive and predictable business climates fuel innovation, manufacturing and growth. @CNBC recognized Ohio and North Carolina as the top 2 states for business. Amgen is proud to have recently invested nearly $2 billion across both states to strengthen our U.S. manufacturing.
00:00
Amgen 🧪🔬🧬
@Amgen
Jun 29
Amgen has invested nearly $2 billion in the U.S. over the last year, building on more than $40 billion invested in U.S. manufacturing and R&D since 2018. The TCJA, reinforced by the One Big Beautiful Bill Act, supports continued investment in domestic science and manufacturing.
Amgen 🧪🔬🧬
@Amgen
Jun 23
Clinical trials are key to turning scientific discovery into new medicines for patients. We appreciate @HHSGov for convening a Clinical Trials Roundtable and discussing ways to reduce research barriers, expand access to research opportunities, and help bring innovation to
Amgen 🧪🔬🧬
@Amgen
Jun 17
What’s next for #biosimilars? At Amgen, continued development and manufacturing expertise is helping drive what’s ahead. Watch to learn more: amgen.ly/4eg6DdX
00:00
Amgen 🧪🔬🧬
@Amgen
Jun 16
NC’s life sciences ecosystem is driving innovation, growth & opportunity. With more than $1.5 billion invested in the state, Amgen is proud to be part of that momentum. In @BusinessNC, Amgen's Paul Lewus shares how the Research Triangle can maintain its leadership in life
Amgen 🧪🔬🧬
@Amgen
Jun 11
Ohio’s thriving manufacturing hub shows what’s possible when innovation, talent, and pro-growth tax policies align. We're proud to be part of this momentum, investing more than $1.4B in Ohio to help strengthen U.S. leadership in biotech. amgen.ly/3S2ARZd
Amgen 🧪🔬🧬
@Amgen
Jun 7
NEWS: At #ADASciSessions 2026, we’re advancing the conversation around cardiometabolic care. New data reinforce the need for more integrated approaches to prevention, risk reduction, and long-term management across obesity, diabetes and cardiovascular disease. 🔗 Read more:
00:00
Amgen 🧪🔬🧬
@Amgen
Jun 4
People living with cardiometabolic conditions often face interconnected risks that can compound over time. This week at @AmDiabetesAssn’s #ADASciSessions, we’re helping advance the conversation around a more integrated approach to obesity, diabetes and cardiovascular disease and
Amgen 🧪🔬🧬
@Amgen
Jun 3
How will AI shape the future of Amgen? CEO Bob Bradway recently joined Sarah Elk and AI pioneer @AndrewYNg on @BainandCompany's Winning with AI podcast to discuss how AI is helping accelerate innovation across drug discovery, development, and manufacturing. 🎙️Watch the full
00:00
Amgen 🧪🔬🧬
@Amgen
Jun 3
📢 Amgen announced the presentation of new data across rare autoimmune & inflammatory diseases at #EULAR2026. Research highlights IgG4-related disease & real-world evidence in ANCA-associated vasculitis. 🔗 Learn more: amgen.ly/4a8lyEu $AMGN
00:00
Amgen 🧪🔬🧬
@Amgen
Jun 1
🔬 Small cell lung cancer news: Amgen’s DLL3-targeting therapy is now approved in the European Union for certain patients with extensive-stage small cell lung cancer (#SCLC). 🔗 Learn more: amgen.ly/4feYaZr
00:00
Amgen 🧪🔬🧬
@Amgen
May 29
Cancer research doesn't stand still at Amgen. At #ASCO2026, we’re sharing new data in SCLC, colorectal cancer, prostate cancer, Ewing sarcoma & more. ➡️ Explore full abstracts: amgen.ly/43nAc7j
00:00
Amgen 🧪🔬🧬
@Amgen
May 19
Amgen announced the planned retirement of EVP and CFO Peter Griffith. Thomas Dittrich will return to Amgen and succeed Griffith as CFO effective Sept. 1, 2026. “We are grateful to Peter for his leadership and lasting impact on the company,” said Chairman and CEO Robert A.
00:00
Amgen 🧪🔬🧬
@Amgen
May 19
A major milestone in our more than $1.5 billion investment in Holly Springs, North Carolina. The final steel topping beam is now in place at Amgen’s newest advanced manufacturing facility — expanding U.S. biomanufacturing capabilities for the future. $AMGN